Ag + /Hg 2+ -Controlled Programmable DNA Nanostructures Enable Tumor Liquid Biopsy by Mass Spectrometry Simultaneous Sensing of Multiple Circulating Tumor DNAs
Analytical Chemistry · 04.11.2025 · 97 (43) · 24260-24269
DOI: 10.1021/acs.analchem.5c05543 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Chemistry, online erschienen am 23.10.2025. Verfasst von Wanqian Lai und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Chemistry and Material Science, Sichuan Normal University, Chengdu, Sichuan 610068, China. Hauptthemen laut MEDLINE: Circulating Tumor DNA, Silver, Lung Neoplasms, Nanostructures. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: West China Hospital, Sichuan University, Key Lab of Process Analysis and Control of Sichuan Universities of China, Science and Technology Department of Sichuan Province.
Abstract (Originalsprache)
Circulating tumor DNA (ctDNA) has emerged as a critical noninvasive biomarker for cancer diagnosis and monitoring. To effectively capture tumor heterogeneity, we developed a rapid, homogeneous, and label-free method for the simultaneous detection of EGFR L858R and 19 del mutations in lung cancer, employing a filter-membrane-assisted separation strategy coupled with inductively coupled plasma mass spectrometry (ICP-MS). The assay utilized functional Y-shaped DNA nanospheres, self-assembled through T-Hg2+-T and C-Ag+-C coordination, enabling highly specific target recognition and efficient release of metal reporters. Following filtration, free Hg2+ and Ag+ ions were quantitatively measured by ICP-MS, facilitating multiplexed ctDNA detection with high sensitivity. The method demonstrated a wide linear range from 10 aM to 10 pM, with detection limits as low as 4.3 aM for L858R and 3.7 aM for 19 del. Clinical validation using 42 plasma samples revealed 100% specificity and 96.9% sensitivity, closely aligning with the pathological findings. Receiver operating characteristic (ROC) analysis achieved an area under the curve (AUC) of 0.94, highlighting the excellent diagnostic accuracy of this approach. This strategy provides a robust, noninvasive platform for precise lung cancer diagnosis and treatment monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- College of Chemistry and Material Science, Sichuan Normal University, Chengdu, Sichuan 610068, China.
- Department of Laboratory Medicine, Department of General Surgery, Med+X Center for Manufacturing, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
ORCID-Profile: Ke Huang, Piaopiao Chen
Förderung
- West China Hospital, Sichuan University
- Key Lab of Process Analysis and Control of Sichuan Universities of China
- Science and Technology Department of Sichuan Province
- National Natural Science Foundation of China
Zitieren
APA
Lai, W., Huang, X., Zhao, X., Song, X., Wu, Y., Wang, Y., Huang, K., & Chen, P. (2025). Ag + /Hg 2+ -Controlled Programmable DNA Nanostructures Enable Tumor Liquid Biopsy by Mass Spectrometry Simultaneous Sensing of Multiple Circulating Tumor DNAs. Analytical Chemistry, 97(43), 24260-24269. https://doi.org/10.1021/acs.analchem.5c05543
Vancouver
Lai W, Huang X, Zhao X, Song X, Wu Y, Wang Y, et al. Ag + /Hg 2+ -Controlled Programmable DNA Nanostructures Enable Tumor Liquid Biopsy by Mass Spectrometry Simultaneous Sensing of Multiple Circulating Tumor DNAs. Analytical Chemistry. 2025;97(43):24260-24269. doi:10.1021/acs.analchem.5c05543
BibTeX
@article{Lai2025,
author = {Lai, Wanqian and Huang, Xinyuan and Zhao, Xin and Song, Xuemei and Wu, Yiman and Wang, Yue and Huang, Ke and Chen, Piaopiao},
title = {Ag + /Hg 2+ -Controlled Programmable DNA Nanostructures Enable Tumor Liquid Biopsy by Mass Spectrometry Simultaneous Sensing of Multiple Circulating Tumor DNAs},
journal = {Analytical Chemistry},
year = {2025},
volume = {97},
number = {43},
pages = {24260--24269},
doi = {10.1021/acs.analchem.5c05543}
}
EUVIMED